SG Americas Securities’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$781K Sell
45,103
-321,041
-88% -$5.56M ﹤0.01% 1204
2025
Q1
$8.01M Buy
366,144
+313,743
+599% +$6.86M 0.03% 326
2024
Q4
$1.67M Buy
52,401
+28,932
+123% +$923K 0.01% 571
2024
Q3
$677K Sell
23,469
-84,092
-78% -$2.43M ﹤0.01% 1251
2024
Q2
$4.13M Buy
107,561
+60,026
+126% +$2.3M 0.02% 588
2024
Q1
$2.79M Sell
47,535
-1,366
-3% -$80.3K 0.01% 699
2023
Q4
$2.93M Sell
48,901
-125,668
-72% -$7.52M 0.03% 454
2023
Q3
$6.64M Buy
174,569
+73,458
+73% +$2.79M 0.08% 198
2023
Q2
$9.21M Buy
101,111
+90,048
+814% +$8.2M 0.07% 164
2023
Q1
$730K Sell
11,063
-20,319
-65% -$1.34M 0.01% 1287
2022
Q4
$1.62M Buy
31,382
+3,520
+13% +$182K 0.02% 560
2022
Q3
$1.9M Sell
27,862
-23,894
-46% -$1.63M 0.02% 502
2022
Q2
$2.34M Buy
51,756
+47,611
+1,149% +$2.15M 0.02% 556
2022
Q1
$211K Sell
4,145
-173,589
-98% -$8.84M ﹤0.01% 2143
2021
Q4
$8.4M Sell
177,734
-6,280
-3% -$297K 0.05% 264
2021
Q3
$6.07M Buy
184,014
+159,061
+637% +$5.24M 0.03% 390
2021
Q2
$1.58M Buy
24,953
+7,142
+40% +$451K 0.01% 1158
2021
Q1
$764K Buy
17,811
+15,070
+550% +$646K ﹤0.01% 1556
2020
Q4
$157K Sell
2,741
-32,198
-92% -$1.84M ﹤0.01% 2444
2020
Q3
$1.05M Buy
34,939
+30,108
+623% +$908K 0.01% 944
2020
Q2
$158K Sell
4,831
-6,696
-58% -$219K ﹤0.01% 2635
2020
Q1
$309K Buy
11,527
+2,905
+34% +$77.9K ﹤0.01% 1840
2019
Q4
$264K Sell
8,622
-57,187
-87% -$1.75M ﹤0.01% 1968
2019
Q3
$1.59M Buy
+65,809
New +$1.59M 0.01% 983
2019
Q2
Sell
-5,762
Closed -$112K 2528
2019
Q1
$112K Buy
+5,762
New +$112K ﹤0.01% 2611